Anupam Rasayan India Limited (ARIL) reported consolidated unaudited results for the quarter ended 31 December 2025, with total revenue of Rs 5,145 million (mn), up 33 per cent year-on-year. EBITDA including other income stood at Rs 1,296 mn, up seven per cent, yielding an EBITDA margin of 25.20 per cent for the quarter. Profit after tax was Rs 606 mn, reflecting a 12 per cent increase year-on-year. For the nine months of FY26 the company delivered consolidated revenue of Rs 17,297 mn and EBITDA of Rs 4,024 mn, reflecting strong year-on-year growth. The company indicated that Q3 revenue on another measure stood at Rs 5,124 mn with EBITDA of Rs 1,296 mn, demonstrating continued growth momentum. During the period the company signed a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States, which the company said would strengthen its global footprint and enhance capabilities in advanced custom synthesis and access to regulated markets and innovator customers. Management characterised the transaction as an important step towards becoming a global specialty chemical platform. Anupam Rasayan India Limited is a leading provider of custom synthesis and specialty chemicals in India and was incorporated in 1984. Its life science related specialty chemicals vertical includes products for agrochemicals, personal care and pharmaceuticals while the other specialty chemicals vertical comprises polymer additives. The company manufactures products for more than 75 domestic and international customers, including 31 multinational companies. It operates six manufacturing facilities in Gujarat, with four at Sachin, Surat and two at Jhagadia, Bharuch, and an aggregate installed capacity of about 30,000 tonnes (t) as of 31 March 2025. The company offers multistep synthesis and undertakes complex chemical reaction technologies while focusing on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimisation. For further information investor relations are through Ernst & Young LLP and media enquiries via the public relations adviser.